An activist group's concern about maverick genome sequencer J. Craig Venter's intention to patent an entirely synthetic free-living organism has thrown a spotlight on the emerging intellectual-property landscape in this hot new field. The protesters claim that Venter wants his company to become the Microsoft of synthetic biology, dominating the industry.
No takes yet. Share an insight, caveat, or question.
Jocelyn Kaiser (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: